Recombinant factor VIIa in the management of pulmonary hemorrhage associated with metastatic choriocarcinoma

Journal of Clinical Oncology

Volumn 26, Issue 6, 2008, Pages 1008-1010

  Wheater, Matthew J ^a   Mead, Graham M ^a   Bhandari, Sandeep ^a   Fennell, Jonathan ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; BLEOMYCIN; CHORIONIC GONADOTROPIN; CISPLATIN; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE; LACTATE DEHYDROGENASE; PACLITAXEL; PLATINUM; RECOMBINANT BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 7A; CHORIONIC GONADOTROPIN BETA SUBUNIT; RECOMBINANT PROTEIN; TUMOR MARKER;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANAMNESIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; CASE REPORT; CHORIOCARCINOMA; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; DOSE RESPONSE; HOSPITAL ADMISSION; HUMAN; LUNG HEMORRHAGE; LYMPHADENOPATHY; MALE; MULTIPLE CYCLE TREATMENT; NEPHROSTOMY; PNEUMONIA; PRESCRIPTION; PRIORITY JOURNAL; RETROPERITONEAL TUMOR; TREATMENT OUTCOME; TREATMENT RESPONSE; BLOOD; BRAIN TUMOR; CHEMICALLY INDUCED DISORDER; HEMOPTYSIS; LUNG TUMOR; METASTASIS; PATHOLOGY; RADIOGRAPHY;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CHORIOCARCINOMA, NON-GESTATIONAL; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; FACTOR VIIA; HEMOPTYSIS; HUMANS; LUNG NEOPLASMS; MALE; RECOMBINANT PROTEINS; RETROPERITONEAL NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL;

EID: 39749181191     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.14.8486     Document Type: Article

References (13)

1. McKendrick JJ, Theaker J, Mead GM: Nonseminomatous germ cell tumor with very high serum human chorionic gonadotropin. Cancer 67:684-689, 1991
2. Benditt JO, Farber HW, Wright J, et al: Pulmonary hemorrhage with diffuse alveolar infiltrates in men with high-volume choriocarcinoma. Ann Intern Med 109:674-675, 1988
3. Fizazi K, Massard C, Postel-Vinay S, et al: Chemotherapy for poor prognosis non seminomatous germ cell tumors (NSGCT): Should doses be reduced at first cycle to prevent acute respiratory distress syndrome (ARDS) in patients with multiple lung metastases? J Clin Oncol 25:18S, 2007 (suppl; abstr 5087)
4. International Germ Cell Consensus Classification: A prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 15:594-603, 1997
5. Kondagunta GV, Bacik J, Donadio A, et al: Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors. J Clin Oncol 23:6549-6555, 2005
6. Bedano PM, Brames MJ, Williams SD, et al: Phase II study of cisplatin plus epirubicin salvage chemotherapy in refractory germ cell tumors. J Clin Oncol 24:5403-5407, 2006
7. Einhorn L WS, Chamness, Brames MJ, et al: High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumours. N Engl J Med 357:340-348, 2007
8. Brames M, Papiani G,, Einhorn L: Results with salvage chemotherapy with high dose carboplatin + etoposide and peripheral blood stem cell transplant in male choriocarcinoma. J Clin Oncol 25:18S, 2007 (suppl; abstr 5091)
9. Macdonald JA, Fraser JF, Foot CL, et al: Successful use of recombinant factor VII in massive hemoptysis due to community-acquired pneumonia. Chest 130:577-579, 2006
10. Pastores SM, Papadopoulos E, Voigt L, et al: Diffuse alveolar hemorrhage after allogeneic hematopoietic stem-cell transplantation: Treatment with recombinant factor VIIa. Chest 124:2400-2403, 2003
11. Monroe DM, Hoffman M, Oliver JA, et al: A possible mechanism of action of activated factor VII independent of tissue factor. Blood Coagul Fibrinolysis 9:S15-20, 1998 (suppl 1)
12. Hoffman M, Monroe DM 3rd, Roberts HR: Activated factor VII activates factors IX and X on the surface of activated platelets: Thoughts on the mechanism of action of high-dose activated factor VII. Blood Coagul Fibrinolysis 9:S61-5, 1998 (suppl 1)
13. Hedner U: NovoSeven as a universal haemostatic agent. Blood Coagul Fibrinolysis 11:S107-11, 2000 (suppl 1)